Area of research
Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiovascular Function and Risk Factors, Diabetes Treatment and Management, COVID-19 Clinical Research Studies, and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
A Geriatric Assessment Score Predicting 1-Year Mortality and Functional Decline After TAVR
Environmental Pollutant-Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics.
Effects of GLP-1 RA Initiation in Patients With HFrEF and Implantable Cardiac Devices Divided for BMI Values.
Phenotypes of Vulnerability and Prognosis in Older Adults with Cardiovascular Disease.
Micro- and Nanoplastics as Disruptors of Digestive and Hepatopancreatic Homeostasis: Insights into the Plastic-Gut-Liver Axis.
Temporal Trend in Accumulation of Microplastics in Decedent Human Lungs
Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications.
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis.
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.
Effects of Combined Therapy with SGLT2i and GLP-1RAs on Atrial Fibrillation Recurrence After Catheter Ablation in Diabetic Cohorts: One-Year Outcomes from Continuous Monitoring.
PCSK9 Inhibitors "Fast Track" Use Versus "Stepwise" Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a "Real-World" Population.
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study.
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor use.
Obstructive Sleep Apnea and Type 2 Diabetes: An Update.
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers.
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm.
Correction: Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis.
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study.
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Insulin-Heart Axis: Bridging Physiology to Insulin Resistance.
Advances in Nanomedicine for Precision Insulin Delivery.
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis.
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care.
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.
Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease.
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions.
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments.